Nanexa is a nanotechnology company. The main business is focused on Drug-Delivery where the company has developed a technological platform that is used to improve conditions in pharmaceutical formulations and in the release of various medicines. Additionally, the company provides antifungal coating and low friction surface for peripheral venous catheters. The company was established in 2006 and is based in Uppsala.

Quotes for Nanexa AB

Right Now

+/-
0.56
%
8,97%
Latest
6.8
High
6.9
Low
6.3
Volume
70 336
Turnover (SEK)
458 757
Value (MSEK)
144,3

Board

CEO

  • David Westberg

Chairman Of The Board

  • Hans Arwidsson

Board

  • Anders Johansson
  • Bengt Gustavsson
  • Magnus Westgren
  • Otto Skolling
  • Urban Paulsson

Videos

Largest Owners

Name Capital % Votes % Date
Nordnet Pensionsförsäkring 9,24 9,24 2019-12-31
Avanza Pension 7,14 7,14 2019-12-31
Rutger Arnhult 7,00 7,00 2019-12-31
Ivar Nordqvist 5,16 5,16 2019-12-31
Jan Petersen 3,59 3,59 2019-12-31
Mårten Rooth 2,73 2,73 2019-12-31
Anders Johansson 2,68 2,68 2019-12-31
Manligheten AB 2,25 2,25 2019-12-31
CJ Invest 1,98 1,98 2019-12-31
Mats Boman 1,94 1,94 2019-12-31
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream

Upcoming reports

  • 2020-05-15 Delårsrapport 2020-Q1

  • 2020-06-02 Årsstämma 2019

  • 2020-08-20 Delårsrapport 2020-Q2

  • 2020-11-12 Delårsrapport 2020-Q3

  • 2021-02-18 Bokslutskommuniké 2020